Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Violet oil vs sweet almond oil for capecitabine-induced hand-foot syndrome
IRCT20250124064505N1Phase 3Recruiting
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of almond oil in Erythrodysesthesia syndrome (PPE) and dermatitis (2 arms), sponsored by Sabzevar University of Medical Sciences. Started May 2025; status: recruiting.
02
Drugs
almond oil
03
Conditions
Erythrodysesthesia syndrome (PPE)dermatitis
Beyond the preview
Go deeper on IRCT20250124064505N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250124064505N1.